Spironolactone Tablet, Film Coated
Product Images NDC 63629-2437

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 63629-2437). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

FDA Label Image

Figure01 (Fig01)

This text is presenting the statistical data of a clinical trial comparing Spironolactone with Placebo over a time period of 2 months. The Logerankp value is less than 0.001 which indicates a significant difference between the two groups. The number of participants in the Spironolactone group is 82 while n=841 in the Placebo group.*

FDA Label Image

Figure02 (Fig02)

FDA Label Image

Label (Lbl636292437)

This is a description of a medication called Spironolactone in tablet form. Each tablet contains 25mg of the active ingredient. It should be stored at room temperature and away from children, in a light-resistant container with child-resistant closure. The NDC (National Drug Code) for this medication is 63629-2437-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.